CenExel

👋 Get to know the people driving research across the CenExel network.

Today we're highlighting Dr. Josh Rothstein, Principal Investigator at CenExel Atlanta. His diverse clinical background and commitment to advancing patient care help bring high-quality research opportunities to the communities we serve.

New publication announcement 📣

CenExel is proud to support innovative research advancing potential new treatments for chronic neuropathic pain.

A Phase 1/2a trial evaluating KLS-2031, an investigational gene therapy for lumbosacral radiculopathy-induced neuropathic pain, has been published in PAIN Reports.

Congratulations to Dr. Todd Bertoch and the study team on this important publication and contribution to advancing gene therapy research!

Read more at the link in bio!

⭐️ Another reason we do what we do.

Huge shoutout to the incredible team at CenExel Decatur for creating such a welcoming and supportive experience for our participants. From first-time volunteers to returning patients, compassionate care leaves a lasting impact. 💙

Thank you to Nurses Delight, Victoria, Cheral, Maria, and Coordinator Justina for going above and beyond!